How to Get Crestor (Rosuvastatin) in New York

Who Can Prescribe Rosuvastatin in New York

Any New York-licensed physician (MD or DO), nurse practitioner, or physician assistant can prescribe rosuvastatin. New York law allows nurse practitioners to move to independent practice after a defined period of collaborative practice; supervision requirements for PAs and the exact NP threshold are set in state statute and have changed in recent years, so confirm the current rule with the New York State Education Department rather than relying on a fixed number here.

MDs and DOs

Primary care physicians, internists, and cardiologists are the most common prescribers. A cardiologist or lipid specialist may be preferred for atherosclerotic cardiovascular disease (ASCVD) or familial hypercholesterolemia, since these conditions often call for higher doses (20 mg to 40 mg) and closer lipid monitoring.

Nurse Practitioners

New York NPs who have completed the state's required period of collaborative practice can independently evaluate a lipid panel, start rosuvastatin, and manage dose titration. Telehealth NP visits are a common path to a statin prescription.

Physician Assistants

PAs prescribe rosuvastatin under a supervising physician. Supervision does not require the physician to be present for every encounter, so PA-led telehealth visits are a valid prescribing pathway.

Telehealth Access to Rosuvastatin in New York

New York permits telehealth prescribing for rosuvastatin. This can be an efficient path to a prescription, particularly for patients in counties with fewer cardiologists.

How a Telehealth Visit Works

A typical rosuvastatin telehealth visit runs 10 to 20 minutes. The provider reviews medical history, current medications, and recent labs. If a lipid panel from the past year shows elevated LDL-C, many providers can prescribe the same day. Without recent labs, expect a lab order before the prescription is issued.

Platforms That Serve New York

HealthRX.com and other licensed telehealth platforms connect New York residents with providers who evaluate cardiovascular risk and prescribe statins. The 2013 ACC/AHA cholesterol guideline described four statin benefit groups used to guide this kind of decision [2], and telehealth providers generally work from the same framework. The practical advantage of telehealth is no commute and an e-prescription sent directly to a New York pharmacy.

Prescriptions for Existing Patients

Patients already taking rosuvastatin who relocate to New York can usually get a refill through a telehealth visit that documents current dose and recent lipid results. Many providers issue a 90-day prescription with refills once continuity of care is established.

Required Labs Before Starting Rosuvastatin

A responsible provider will not start a statin without reviewing lipid and liver values first.

Baseline Lipid Panel

A fasting lipid panel measures total cholesterol, LDL-C, HDL-C, and triglycerides. The 2018 AHA/ACC multi-society cholesterol guideline recommends using a 10-year ASCVD risk estimate to guide statin intensity, and identifies patients with LDL-C at or above 190 mg/dL as candidates for high-intensity statin therapy independent of the calculated risk score [3].

Hepatic Function Panel

ALT and AST are typically checked before starting therapy. The rosuvastatin prescribing information generally lists active liver disease as a contraindication. If ALT is more than three times the upper limit of normal, rosuvastatin should not be started until the cause is evaluated.

Follow-Up Labs

A repeat lipid panel 4 to 12 weeks after starting or changing dose is standard practice to assess response. The STELLAR trial, which compared rosuvastatin against other statins across a dose range, found dose-dependent LDL-C lowering with rosuvastatin, generally in the range of roughly 45% to 55% versus baseline at doses from 10 mg to 40 mg [5]. Individual response varies, and the exact percentage for a given dose should not be treated as a guarantee. If the target LDL-C is not reached, a provider may increase the dose, add a second agent such as ezetimibe, or refer to the 2022 ACC expert consensus pathway on nonstatin therapies for additional options [6].

Insurance Coverage and Cost in New York

What you pay depends on whether you fill brand Crestor or generic rosuvastatin, and which plan you carry. Prices, tiers, and coupon eligibility change often and should be checked directly rather than assumed from this article.

Generic Rosuvastatin Pricing

Generic rosuvastatin has been available since patent expiration in 2016 from manufacturers including Teva, Sandoz, and Aurobindo. Cash prices for a 30-day supply commonly fall in the $8 to $25 range at New York pharmacies, though prices vary by pharmacy and change over time. Compare current prices before assuming a specific number applies to you.

Brand Crestor Pricing

Brand Crestor has a list price well above generic rosuvastatin. AstraZeneca has historically offered a savings card for commercially insured patients, but federal anti-kickback rules generally bar manufacturer coupons for Medicare and Medicaid beneficiaries. Confirm current eligibility with the manufacturer or your pharmacist.

New York Medicaid

New York Medicaid generally covers rosuvastatin for hyperlipidemia and ASCVD prevention, typically with prior authorization. A PA request commonly requires a diagnosis code, a recent lipid panel, and documentation that the patient meets statin benefit group criteria. Exact requirements and turnaround times change and should be verified with the current Medicaid pharmacy policy.

Commercial Insurance

Many commercial plans place generic rosuvastatin on a low copay tier and reserve prior authorization or step therapy for the brand. The JUPITER trial's strong outcome data for rosuvastatin 20 mg [1] is one reason insurers commonly do not restrict the generic, but formularies differ by plan and change from year to year, so check your specific plan's current formulary rather than assuming a tier.

Medicare Part D

Most Medicare Part D plans cover generic rosuvastatin. Under the Inflation Reduction Act, Medicare Part D enrollees have had an annual out-of-pocket cap on covered drug costs starting in 2025, which limits what a beneficiary pays across the year regardless of which covered drugs they use. Confirm the current plan-year cap and your specific plan's cost-sharing structure, since these are set annually.

Prior Authorization in New York

Some payers, notably Medicaid and certain Medicare Advantage plans, require prior authorization before covering rosuvastatin.

What Documentation You Need

A PA request typically includes:

• Patient diagnosis (hyperlipidemia, ASCVD, or familial hypercholesterolemia)
• Recent lipid panel results with the date drawn
• 10-year ASCVD risk score, for primary prevention patients
• Documentation of statin intolerance or therapeutic failure, if applicable
• Clinical rationale for rosuvastatin if the plan's preferred statin is a different agent

Timeline

New York's utilization review requirements generally set response windows for standard versus urgent prior authorization requests, with urgent requests handled faster than standard ones. Exact deadlines are set in state law and regulation and can be amended, so confirm the current requirement with the New York State Department of Financial Services or your plan rather than relying on a specific number carried over from an older source.

Avoiding PA on Commercial Plans

Many commercial plans do not require PA for generic rosuvastatin even when they do for the brand. If a plan requires PA for Crestor specifically, switching to generic rosuvastatin often avoids the requirement, since PA is frequently applied to brand-name drugs that have a generic alternative.

New York Rosuvastatin Access: What's Stable and What You Must Verify

Facts about a specific drug and its FDA label rarely change. Facts about a specific insurer, state program, pharmacy, or price change constantly. Confusing the two is a common source of outdated guidance. Use this checklist to separate them before acting on anything in this article.

Stable clinical and federal facts (low risk of having changed):

• Rosuvastatin is FDA-approved for hyperlipidemia and cardiovascular risk reduction in appropriate patients, with a labeled dose range of 5 mg to 40 mg once daily
• Active liver disease is generally considered a labeled contraindication
• The FDA label is reported to recommend a 5 mg starting dose in patients of Asian ancestry due to higher plasma concentrations related to OATP1B1 transporter activity
• Rosuvastatin is not a federally controlled substance
• Baseline and follow-up lipid and liver testing are standard practice around statin initiation
• The core trial evidence for rosuvastatin (JUPITER, STELLAR) is published and stable [1][5]

Date-sensitive facts that must be checked at the time of use (do not assume these from this article):

• Whether your specific New York Medicaid or Medicare Advantage plan requires prior authorization for rosuvastatin, and what documentation it currently demands
• The current statutory response deadline for New York prior authorization requests
• Which formulary tier and copay your specific commercial plan assigns to generic versus brand rosuvastatin
• Current manufacturer coupon eligibility rules for brand Crestor
• The current Medicare Part D annual out-of-pocket cap and your plan's cost-sharing structure for the plan year
• Cash price for generic or brand rosuvastatin at a specific New York pharmacy
• The current New York statute governing NP independent practice hours and PA supervision requirements
• Current 503A compounding pharmacy licensing and state board requirements

If a fact belongs in the second list, verify it directly with the payer, pharmacy, or state agency before relying on it, even if it appears elsewhere in this article.

Pharmacy Options in New York

New York has a dense pharmacy network across retail, mail-order, and compounding channels.

Retail Pharmacies

CVS, Walgreens, Rite Aid, and Duane Reade locations across the state stock generic rosuvastatin and generally accept e-prescriptions from telehealth visits, often with same-day fill.

Mail-Order Pharmacies

Mail-order services such as Express Scripts, OptumRx, and Amazon Pharmacy typically offer 90-day supplies. For a long-term maintenance medication like rosuvastatin, mail-order can lower per-unit cost compared with repeated 30-day retail fills, though savings vary by plan.

503A Compounding Pharmacies

New York-licensed 503A compounding pharmacies can prepare rosuvastatin in an alternative dosage form, such as a liquid suspension, for a patient with a documented clinical need who cannot use a commercial tablet. Compounded rosuvastatin is patient-specific, not a substitute for commercially manufactured tablets, and is typically more expensive. Compounders are expected to follow USP nonsterile compounding standards under state pharmacy board oversight; confirm a specific pharmacy's current licensing status directly.

Transferring a Prescription to New York

Rosuvastatin is not a controlled substance, so transferring a prescription from another state to a New York pharmacy is generally straightforward. The receiving pharmacy verifies the prescription with your previous pharmacy; this commonly takes a day or two, though timing varies by pharmacy.

Rosuvastatin Dosing and Monitoring After Access

Dose Selection

The 2018 AHA/ACC cholesterol guideline classifies statin therapy by intensity [3]:

• Moderate intensity: rosuvastatin 5 mg to 10 mg daily
• High intensity: rosuvastatin 20 mg to 40 mg daily

Adults aged 40 to 75 with a sufficiently elevated 10-year ASCVD risk score are typically candidates for moderate-to-high intensity therapy under this framework. The JUPITER trial enrolled adults with LDL-C below 130 mg/dL but elevated high-sensitivity CRP, and still found a significant benefit from rosuvastatin 20 mg, which is part of why hsCRP is sometimes considered alongside LDL-C in risk discussions [1].

Monitoring Schedule

Check a fasting lipid panel and liver function 4 to 12 weeks after starting or changing dose. If the medication is tolerated and LDL-C is at target, labs commonly move to an every-3-to-12-month schedule depending on clinical stability. Report new muscle pain, dark urine, or unexplained weakness to a provider promptly, since these can signal rhabdomyolysis, a rare but serious statin adverse effect. Published incidence estimates for rhabdomyolysis on statins vary by data source and population studied; ask your provider for the current estimate rather than relying on a single fixed number.

Special Populations

Patients of Asian ancestry may have higher rosuvastatin plasma concentrations related to OATP1B1 transporter activity, and prescribing guidance is generally understood to recommend starting at 5 mg in this population. Patients with an eGFR below 30 mL/min/1.73 m² generally should not exceed 10 mg daily without close nephrology involvement; this should be individualized with the treating provider, not self-managed from general guidance.

How Long Until You Receive Rosuvastatin in New York

The timeline depends on where you're starting from.

With recent labs and no PA requirement, a telehealth visit can result in an e-prescription within hours, and most pharmacies fill generic rosuvastatin the same day. Total time is often under 24 hours.

If you need new labs, add roughly 2 to 5 business days for a blood draw and result turnaround at a typical New York lab.

If your plan requires prior authorization, add the time your specific payer needs to process the request, which the prior authorization section above addresses. In a worst case of new labs plus PA, allow roughly a week to ten days from initial visit to filled prescription, understanding that this range is an estimate, not a guarantee.

Guideline authors have generally emphasized that statin therapy should not be delayed unnecessarily in high-risk patients, and that a formulary-preferred statin can sometimes serve as a reasonable starting point while a preferred agent's authorization is pending. If a prior authorization delay concerns you clinically, raise it directly with your prescriber rather than waiting it out.